Effect of trastuzumab on health-related quality of life in patients with HER2-positive metastatic breast cancer: data from three clinical trials. Read more about Effect of trastuzumab on health-related quality of life in patients with HER2-positive metastatic breast cancer: data from three clinical trials.
Unraveling the biologic and clinical complexities of HER2. Read more about Unraveling the biologic and clinical complexities of HER2.
Novel taxane formulations in the treatment of breast cancer: a thought leader discussion and consensus roundtable. Read more about Novel taxane formulations in the treatment of breast cancer: a thought leader discussion and consensus roundtable.
Strategies for the prevention of treatment-related bone loss in women receiving adjuvant hormonal therapy. Read more about Strategies for the prevention of treatment-related bone loss in women receiving adjuvant hormonal therapy.
Statins: health-promoting agents show promise for breast cancer prevention. Read more about Statins: health-promoting agents show promise for breast cancer prevention.
The evolving role of aromatase inhibitors in adjuvant breast cancer therapy. Read more about The evolving role of aromatase inhibitors in adjuvant breast cancer therapy.
Pegylated liposomal doxorubicin and cyclophosphamide as first-line therapy for patients with metastatic or recurrent breast cancer. Read more about Pegylated liposomal doxorubicin and cyclophosphamide as first-line therapy for patients with metastatic or recurrent breast cancer.
A phase II trial of gemcitabine in patients with metastatic breast cancer previously treated with an anthracycline and taxane. Read more about A phase II trial of gemcitabine in patients with metastatic breast cancer previously treated with an anthracycline and taxane.
Patient and physician attitudes toward breast cancer clinical trials: developing interventions based on understanding barriers. Read more about Patient and physician attitudes toward breast cancer clinical trials: developing interventions based on understanding barriers.
The impact of alternative practices on the cost and quality of mammographic screening in the United States. Read more about The impact of alternative practices on the cost and quality of mammographic screening in the United States.
